title: Macular hole following Bartonella henselae neuroretinitis.
abstract: OBJECTIVE
  To report a case of macular hole secondary to Bartonella henselae neuroretinitis.
  
  
  METHODS
  Observational case report. An 11 year-old boy presented urgently with a decrease of visual acuity in the left eye. Posterior segment examination revealed neuroretinitis attributed to Bartonella henselae. Treatment was initiated, resulting in the disappearance of symptoms.
  
  
  RESULTS
  Follow-up consultations 7 months later showed a further decline in visual acuity secondary to a macular hole.
  
  
  CONCLUSIONS
  Cat scratch disease is a rare pathology and is most often considered benign. Serious complications can nonetheless occur, such as neuroretinitis, choroidal nodules, and disciform keratitis. The authors report a case of sequellar macular hole. They found only one previous report of macular hole caused by B henselae, which, contrary to their case, appeared rapidly 12 days after presentation.
authors.affiliation: Service d'Ophtalmologie, Centre Hospitalier Universitaire de Fort de France, Hopital Pierre Zobda-Quitman, Fort de France Cedex, Martinique - France (French West Indies).
authors.forename: A
authors.initials: A
authors.lastname: Donnio
authors.forename: A
authors.initials: A
authors.lastname: Jean-Charles
authors.forename: H
authors.initials: H
authors.lastname: Merle
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000907:Antibodies, Bacterial / Q000097:blood; D018416:Bartonella henselae / Q000276:immunology / Q000302:isolation & purification*; D002372:Cat-Scratch Disease / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D002648:Child; D004318:Doxycycline / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D015818:Eye Infections, Bacterial / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D019084:Fluorescent Antibody Technique, Indirect; D006801:Humans; D007075:Immunoglobulin M / Q000097:blood; D008297:Male; D012167:Retinal Perforations / Q000209:etiology*; D012173:Retinitis / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D012293:Rifampin / Q000627:therapeutic use; D014792:Visual Acuity
chemical_list: D000900:Anti-Bacterial Agents; D000907:Antibodies, Bacterial; D007075:Immunoglobulin M; D004318:Doxycycline; D012293:Rifampin